Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | REN | P00797 | 9/20 | 0.64 |
| ▸ | CTSS | P25774 | 3/20 | 0.61 |
| ▸ | CTSK | P43235 | 2/20 | 0.61 |
| ▸ | CTSL | P07711 | 1/20 | 0.57 |
| ▸ | CTSB | P07858 | 1/20 | 0.57 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.56 |
| ▸ | ACE | P12821 | 1/20 | 0.55 |
| ▸ | MME | P08473 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20825295 | 0.96 | REN (0.64) | RENCTSSCTSKCTSLCTSB | |
| SCHEMBL18257557 | 0.96 | REN (0.64) | RENCTSSCTSKCTSLCTSB | |
| SCHEMBL18257572 | 0.96 | REN (0.64) | RENCTSSCTSKCTSLCTSB | |
| SCHEMBL23616313 | 0.96 | REN (0.64) | RENCTSSCTSKCTSLCTSB | |
| SCHEMBL18257495 | 0.96 | REN (0.64) | RENCTSSCTSKCTSLCTSB | |
| SCHEMBL28728712 | 0.96 | REN (0.64) | RENCTSSCTSKCTSLCTSB | |
| SCHEMBL13743068 | 0.96 | REN (0.64) | RENCTSSCTSKCTSLCTSB | |
| SCHEMBL18257549 | 0.96 | REN (0.64) | RENCTSSCTSKCTSLCTSB | |
| SCHEMBL15635321 | 0.96 | CTSS (0.65) | RENCTSSCTSKCTSLMAPK1 | |
| SCHEMBL15635322 | 0.96 | CTSS (0.65) | RENCTSSCTSKCTSLMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11084847-B2 | Polyamide compound and use thereof | SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD. (CN) | 2021-08-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11084847-B2 | Polyamide compound and use thereof | OPRK1, OPRM1, OPRD1 | REN 385/4885CTSS 1537/4885CTSK 2207/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.